The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway
Crossref DOI link: https://doi.org/10.1007/s40263-017-0431-2
Published Online: 2017-05-24
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Lin https://orcid.org/0000-0001-7085-7075
License valid from 2017-05-24
